Karen Young | Source | US Health Industries Leader at PwC
Karen Young
US Health Industries Leader at PwC
Recent Quotes
Sign up to view all
-
Funding key research and development and commercial activities are a high priority as companies across the pharmaceutical and life sciences industry look to emerge stronger from the COVID crisis.
Media
Sign up to view all
-
Royalty Pharma goes public as drugmakers seek post-COVID-19 funding strategies
Royalty Pharma filed the largest IPO of 2020 in the second quarter, emerging into a public market amid the COVID-19 pandemic with innovative funding strategies for pharmaceutical companies.
Article
Employment
Sign up to view all
-
PwC
US Health Industries Leader
started Jan 2013
Twitter Feed